Exelixis
EXEL
#1550
Rank
NZ$24.75 B
Marketcap
NZ$99.89
Share price
1.09%
Change (1 day)
53.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company